BioWorld MedTech

Dec. 16, 2013

BioVentrix expands European trial of Revivent-TC via LIVE procedure

An implant intended to address the cause of heart failure that was once implanted during an open-chest procedure in the operating room is now being delivered via a less invasive technique in the catheter lab in a European clinical trial. Read More

Mindray moves upmarket with Zonare acquisition

International report: Echo grants rights to MTIA for Symphony CGM in China

Washington Roundup: Budget bill offers language for medical device tax repeal

Sundance will expand psychiatric evaluation

Grants: Ixico wins grant competition in UK for dementia products

Financings roundup: Xoma to sell common stock in public offering

Med-Tech Notes

People in Places

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 25, 2026.

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026